Furthermore, amyloid deposition, by pathological and imaging staging (amyloid positron emission tomography—PET), does not topographically and functionally correlate with the clinical cognitive decline seen in our patients, while tau does, and there are cases of aged individuals who have amyloid deposition in their brain, but no tau and no clinical dementia [25,37,38]. Here, MAPT is linked to dementia.